Training - EthosCE - DS

December 4, 2018

Pediatric differentiated thyroid cancer (DTC) patients frequently present with lymph node and/or distant (lung) metastases. Such patients warrant an aggressive treatment consisting of surgical removal of all surgically accessible local metastases as well as further treatment with one or more courses of radioiodine therapy (RAI). It is still a subject of debate in literature how much I-131 should be administered to pediatric patients. Patients can either be given a fixed (possibly body weight adjusted) activity or a dosimetry based activity, which is often considerably higher


Target Audience

Endocrinologists/Pediatric  Endocrinologists

Radiologists

Learning Objectives

Learners will be able to:

  • Have an understanding of different approaches to dosimetry of radioiodine therapy
  • Determine best approach for treating patient
Course summary
Available credit: 
  • 0.00 AMA PRA Category 1 Credit™
Course opens: 
11/30/2018
Course expires: 
11/01/2019
Event starts: 
12/04/2018 - 1:00pm
Event ends: 
12/04/2018 - 5:00pm
Cost:
$0.00
Rating: 
0

The following author reported no relevant financial relationships:

Heribert Hänscheid, M.D., has no relevant financial relationships.

The following JCEM Editors reported relevant financial relationships:

The Editor-in-Chief, Leonard Wartofsky, M.D., is a Consultant for Asurogen, Genzyme, and IBSA, and is on the Speaker's Bureau for Genzyme.

Kenneth Burman, M.D., is a Consultant for Medscape and UpToDate; a Reviewer for the Endocrine Fellows Foundation; and has received Institutional Grants for Research from Amgen, Eisei, and Pfizer.

Lynnette Nieman, M.D., is an Author/Editor for UpToDate, and receives Research Support from HRA-Pharmaceutical.

The following JCEM Editors reported no relevant financial relationships: Paolo Beck-Peccoz, M.D.; David Ehrmann, M.D.; David Handelsman, Ph.D.; Michael Kleerekoper, M.D.; Merrily Poth, M.D.; Constantine Stratakis, M.D.

Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

Acknowledgement of Commercial Support

JCEM Journal-based CME activities are not supported by grants, other funds, or in-kind contributions from commercial supporters.

The (NAME OF YOUR ORGANIZATION) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Available Credit

  • 0.00 AMA PRA Category 1 Credit™

Accreditation Period

Course opens: 
11/30/2018
Course expires: 
11/01/2019

Price

Cost:
$0.00
Please login or register to take this course.